CN110105364B - Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof - Google Patents
Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof Download PDFInfo
- Publication number
- CN110105364B CN110105364B CN201910364462.4A CN201910364462A CN110105364B CN 110105364 B CN110105364 B CN 110105364B CN 201910364462 A CN201910364462 A CN 201910364462A CN 110105364 B CN110105364 B CN 110105364B
- Authority
- CN
- China
- Prior art keywords
- substituted maleimide
- chlorophenyl
- terpinene cycloaddition
- terpinene
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative and a preparation method and application thereof, 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-chloroaniline are respectively dissolved in an acetone solvent, p-chloroaniline solution is dripped into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring to prepare an N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product, then the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluoro chromone phenylhydrazone are mixed in absolute ethanol, the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing pyrazole structure prepared by adding chloramine T has stronger inhibitory activity to HL-60, Bel-7402 and ECA109, and provides a foundation for the development and research of potential drugs.
Description
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to an N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, and a preparation method and application thereof.
Background
The chemical structural formula of the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative is shown in figure 1. The 1, 3-dipolar cycloaddition reaction is the most important method for synthesizing five-membered heterocyclic compounds with good regioselectivity and body selectivity, and is also a more active reaction in heterocyclic pharmaceutical chemistry research.
In recent years, chromones have received much attention due to a wide range of biological activities, such as anticancer, antibacterial, inhibition of platelet aggregation, and the like. Therefore, the heterocyclic compound has high synthetic value in terms of pharmacology and synthesis angle. Pyrazole derivatives have attracted considerable attention as a class of useful intermediates and as a variety of pharmaceutical activities that they themselves exhibit.
The influence of different heterocycles on the pharmacological activity caused by the aggregation of the same molecule is researched, the pyrazole N-p-chlorophenyl maleimide alpha-terpinene cycloaddition derivative containing the chromone structure is synthesized through the dipolar cycloaddition reaction, and the method has important significance in the field of medicine research.
Disclosure of Invention
The invention aims to provide an N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, and a preparation method and application thereof.
In order to achieve the purpose, the technical scheme of the invention is as follows:
the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure has the following chemical structural formula:
the invention relates to a preparation method of a pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, which is characterized in that the preparation method of the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative comprises the following steps:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-chloroaniline in an acetone solvent, the parachloroaniline solution is dripped into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring, the reaction releases heat and gradually generates light yellow precipitate, after the reaction is carried out for 1 to 2 hours at room temperature, adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle in sequence, reacting, heating, gradually dissolving the precipitate, reacting for 5-8 hours at 50-60 ℃, changing the solution from orange yellow to red black, cooling to room temperature, washing and drying the precipitate in a large amount of water, and recrystallizing with acetone to obtain the product N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product;
mixing the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluorochromone phenylhydrazone in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative.
Further, the dissolving of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and p-chloroaniline (compound 2) in an acetone solvent, respectively, comprises:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of parachloroaniline into 20-30 mL of acetone solvent.
Further, the molar ratio of the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
Further, the sequentially adding manganese acetate, triethylamine and acetic anhydride comprises:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
Further, the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product and 1mmol of the 6-fluorochromone phenylhydrazone are added per 20-25mL of the anhydrous ethanol.
The invention also provides application of the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative in preparation of antitumor drugs.
The invention provides an N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure, a preparation method and application thereof, wherein the pharmacological activity can be changed by introducing the structure of chromone on the basis of introducing a five-membered pyrazole ring structure into an N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product, 6-fluoro chromone phenylhydrazone substituted by formaldehyde group at the 3-position is used for substituting on the structure of pyrazole, the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product is structurally modified, and the prepared N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing the pyrazole structure has stronger inhibitory activity on HL-60 (leukemia cells), Bel-7402 (human liver cancer cells) and ECA109 (intestinal cancer cells), provides a foundation for the development and research of the compound for potential drugs.
Drawings
FIG. 1 is a chemical structural formula of a cycloaddition derivative of N-p-chlorophenyl substituted maleimide alpha-terpinene;
FIG. 2 is a chemical structural formula of the pyrazole-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative of the present invention;
FIG. 3 is a chemical formula schematic diagram of a preparation method of the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative.
Detailed Description
The technical solutions of the present invention are further described in detail below with reference to the drawings and examples, which should not be construed as limiting the present invention.
Research shows that the pharmacological activity can be changed by introducing the structure of chromone on the basis of introducing a five-membered pyrazole ring structure into the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative. The experimental data are as follows:
TABLE 1
Based on the above experimental data, the structure of the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative is modified by using 6-fluorochromone phenylhydrazone substituted with formaldehyde group at the 3-position to substitute the structure of pyrazole.
The chemical structural formula of the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative containing a pyrazole structure is shown in figure 2.
In one embodiment, a method for preparing an N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition derivative having a pyrazole structure comprises:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and parachloroaniline (compound 2) in an acetone solvent, dropwise adding the parachloroaniline solution (compound 2) into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, discharging heat and gradually generating light yellow precipitates, reacting at room temperature for 1-2 hours, sequentially adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle, reacting for 1-2 hours, heating the reaction, gradually dissolving the precipitates, reacting at 50-60 ℃ for 5-8 hours, changing the solution from orange yellow to red black, cooling to room temperature, washing the precipitate with a large amount of water, drying, and recrystallizing with acetone to obtain the product N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3);
mixing the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 6-fluorochromone phenylhydrazone (compound 4) in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Wherein the chemistry of compound 3 is collectively referred to as: 1-isopropyl-4-methyl-bicyclo [2,2,2] -5-octene-2, 3- (N-p-chlorophenyl) dicarboximide, abbreviated in this example as N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product.
While the chemistry of compound 5 is collectively referred to as: 3- (6-fluoro-chromon-3-yl) -1-phenyl-7-methyl-4-isopropyl-bicyclo [2,2,2] octa [2,3-d ]3aH,7aH pyrazole-2, 3- (N-p-chlorophenyl) dicarboximide, referred to in this example as the pyrazole-containing N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition derivative.
Wherein, the synthesis of the 6-fluorochromone phenylhydrazone (compound 4) can be synthesized by a method of generating Schiff base by dehydration reaction of 6-fluorochromone with substituted formaldehyde group at the 3 position and phenylhydrazine.
Example 1, 2mmol phenylhydrazine was added to a flask containing 10mL tetrahydrofuran, and the mixture was stirred under reflux in a boiling water bath until dissolved, then 20mL absolute ethanol solution in which 2mmol of 6-fluorochromone substituted with a formaldehyde group at the 3-position was dissolved was slowly added dropwise, and the mixture was stirred under reflux in a boiling water bath for 1 hour, and 10 drops of hydrochloric acid were added dropwise, and a pale yellow precipitate appeared. And (3) refluxing and stirring in a continuous boiling water bath for 5 hours, stopping the water bath, adding 20mL of distilled water, stirring, deepening the color of a light yellow precipitate, and performing suction filtration to obtain a yellow-red needle-shaped product of 6-fluorochromone phenylhydrazone. Washing with anhydrous ether for several times, and vacuum drying to obtain the product 6-fluorochromone phenylhydrazone (compound 4).
The present invention is not limited to the method for synthesizing 6-fluorochromone phenylhydrazone (compound 4), and the chemical name of compound 4 may be expressed as: 6-fluoro-chromone-3-phenylhydrazone, which is not described in detail herein.
In one example, 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and p-chloroaniline (compound 2) were dissolved in acetone solvents, respectively, comprising:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of parachloroaniline into 20-30 mL of acetone solvent.
In one embodiment, the molar ratio of N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
In one embodiment, manganese acetate, triethylamine and acetic anhydride are added sequentially, including:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
In one example, the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition product and 1mmol of the 6-fluorochromone phenylhydrazone are added per 20-25mL of the anhydrous ethanol.
The preparation of the N-p-chlorophenyl substituted maleimide α -terpinene cycloaddition derivative (compound 5) containing the pyrazole structure of the present application is illustrated in detail by the following specific examples:
examples 2,
1) And synthesis of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of parachloroaniline (compound 2) in 20mL of acetone solvent, dropwise adding the parachloroaniline solution into a reaction bottle containing the 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting for 1 hour at room temperature, sequentially adding 0.3 g of manganese acetate, 15mL of triethylamine and 30mL of acetic anhydride into the reaction bottle, reacting for 1 hour at room temperature, heating, gradually dissolving the precipitate, reacting for 5 hours at 50-60 ℃, changing the solution from orange yellow to red black, cooling to room temperature, the precipitate was washed with a large amount of water, dried, and recrystallized from acetone to give the product N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product (Compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 20mL of absolute ethanol, adding 1.2mmol of chloramine T, refluxing for 12 hours, performing addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Examples 3,
1) And synthesis of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of parachloroaniline (compound 2) in 30mL of acetone solvent, dropwise adding the parachloroaniline solution into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting for 2 hours at room temperature while releasing heat and gradually generating light yellow precipitates, sequentially adding 0.5 g of manganese acetate, 20mL of triethylamine and 35mL of acetic anhydride into the reaction bottle, reacting for 2 hours at room temperature while heating, gradually dissolving the precipitates, reacting for 8 hours at 50-60 ℃, changing the solution from orange yellow to red black, cooling to room temperature, the precipitate was washed with a large amount of water, dried, and recrystallized from acetone to give the product N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product (Compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 25mL of absolute ethanol, adding 1.5mmol of chloramine T, refluxing for 15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Examples 4,
1) And synthesis of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product: respectively dissolving 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) and 2mmol of parachloroaniline (compound 2) in 25mL of acetone solvent, dropwise adding the parachloroaniline solution into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride (compound 1) solution under stirring, reacting for 2 hours at room temperature while releasing heat and gradually generating light yellow precipitates, sequentially adding 0.4 g of manganese acetate, 18mL of triethylamine and 33mL of acetic anhydride into the reaction bottle, reacting for 2 hours at room temperature while heating, gradually dissolving the precipitates, reacting for 6 hours at 50-60 ℃, changing the solution from orange yellow to red black, cooling to room temperature, the precipitate was washed with a large amount of water, dried, and recrystallized from acetone to give the product N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product (Compound 3).
2) Introduction of a pyrazole structure: mixing 1mmol of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product (compound 3) and 1mmol of 6-fluorochromone phenylhydrazone (compound 4) in 25mL of absolute ethanol, adding 1.4mmol of chloramine T, refluxing for 13 hours, performing addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5).
Figure 3 shows the preparation of compound 5 of the present application, wherein 1 represents compound 1, 2 represents compound 2,3 represents compound 3, 4 represents compound 4, and 5 represents compound 5.
The experimental data are as follows:
the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) containing pyrazole structure is light yellow crystal, the yield is 63.5 percent, and the m.p.192-193 ℃.
1H NMR(DMSO)δ:7.28-7.49(m,12H,Ar-H),6.47(s,1H,C＝C-H),6.01(d,J＝8.5Hz,1H,H-5),6.09(1H,d,J＝8.5Hz,1H,H-6),3.13(1H,d,J＝8.9Hz,1H H-2),2.85(1H,d,J＝8.9Hz,1H,H-3),1.34(1H,m,H-7a),1.47(1H,m,H-7b),1.33(1H,m,H-8a),1.47(1H,m,H-8b),2.56(1H,m,H-9),1.01(3H,d,J＝7.0Hz,H-10),1.07(3H,d,J＝6.7Hz,H-11),1.50(3H,s,H-12).
IR 3457(N-C＝O),3085(ArH),1730(C＝O),1578(C＝N),1292(C-O-C)cm-1
m/e:623(100.0％)。
Anal.calcd.for C36H31FClN3O4:C,69.28；H,5.01；N,6.73。
The result of measuring the antitumor activity of the pyrazole-containing N-p-chlorophenyl-substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) is as follows:
The test compounds at various concentrations were coarse-screened in 96-well plates and, based on the resulting inhibition, IC50 values were calculated and the results are shown in the following table:
TABLE 2
Table 2 shows the IC of N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) containing pyrazole structure on six tumor cell lines50The results show that the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative (compound 5) has stronger inhibitory activity on HL-60 (leukemia cells), Bel-7402 (human liver cancer cells) and ECA109 (intestinal cancer cells), and provides a foundation for the development and research of potential drugs.
The above embodiments are only for illustrating the technical solution of the present invention and not for limiting the same, and those skilled in the art can make various corresponding changes and modifications according to the present invention without departing from the spirit and the essence of the present invention, but these corresponding changes and modifications should fall within the protection scope of the appended claims.
Claims (7)
1. The pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative is characterized in that the chemical structural formula of the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative is as follows:
2. the process for preparing the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 1, wherein the process for preparing the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative comprises:
respectively dissolving 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-chloroaniline in an acetone solvent, the parachloroaniline solution is dripped into a reaction bottle containing 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride solution under stirring, the reaction releases heat and gradually generates light yellow precipitate, after the reaction is carried out for 1 to 2 hours at room temperature, adding manganese acetate, triethylamine and acetic anhydride into the reaction bottle in sequence, reacting, heating, gradually dissolving the precipitate, reacting for 5-8 hours at 50-60 ℃, changing the solution from orange yellow to red black, cooling to room temperature, washing and drying the precipitate in a large amount of water, and recrystallizing with acetone to obtain the product N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product;
mixing the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product and 6-fluorochromone phenylhydrazone in absolute ethyl alcohol, adding chloramine T, refluxing for 12-15 hours, carrying out addition reaction, recrystallizing with methanol, and drying in vacuum to obtain the pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative;
wherein the chemical structural formula of the N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition product is as follows:
the chemical structural formula of the 6-fluorochromone phenylhydrazone is as follows:
3. the method for preparing the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 2, wherein the dissolving of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride and p-chloroaniline in an acetone solvent comprises:
adding 2mmol of 1-isopropyl-4-methyl-bicyclo [2,2,2] oct-5-ene-2, 3-dicarboxylic anhydride into 20-30 mL of acetone solvent;
adding 2mmol of parachloroaniline into 20-30 mL of acetone solvent.
4. The method for preparing the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 2, wherein the molar ratio of the N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product, 6-fluorochromone phenylhydrazone, and chloramine T is 1: 1: 1-1.5.
5. The method for preparing the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 2, wherein the sequentially adding manganese acetate, triethylamine and acetic anhydride comprises:
adding 0.3-0.5 g of manganese acetate into 40-60 mL of acetone solvent;
adding 15-20mL of triethylamine into 40-60 mL of acetone solvent;
30-35mL of acetic anhydride is added into 40-60 mL of acetone solvent.
6. The method for preparing the pyrazole-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 2, wherein the N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product and 6-fluorochromone phenylhydrazone are mixed in anhydrous ethanol, wherein 1mmol of the N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition product and 1mmol of the 6-fluorochromone phenylhydrazone are added per 20 to 25mL of the anhydrous ethanol.
7. The use of the pyrazole structure-containing N-p-chlorophenyl-substituted maleimide α -terpinene cycloaddition derivative according to claim 1 in the preparation of an antitumor agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910364462.4A CN110105364B (en) | 2019-04-30 | 2019-04-30 | Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910364462.4A CN110105364B (en) | 2019-04-30 | 2019-04-30 | Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110105364A CN110105364A (en) | 2019-08-09 |
| CN110105364B true CN110105364B (en) | 2021-08-24 |
Family
ID=67487988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910364462.4A Active CN110105364B (en) | 2019-04-30 | 2019-04-30 | Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110105364B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076989A1 (en) * | 2001-03-23 | 2002-10-03 | The University Of Newcastle Research Associates Limited | Protein phosphate inhibitors |
| CN103896954A (en) * | 2013-11-15 | 2014-07-02 | 绍兴文理学院 | Pyrazol norcantharidin derivative as well as preparation method and application thereof |
| CN106397445A (en) * | 2016-04-29 | 2017-02-15 | 绍兴文理学院 | Pyrazoles N-p-bromophenyl maleimide derivative containing chromone structure as well as preparation method and application thereof |
-
2019
- 2019-04-30 CN CN201910364462.4A patent/CN110105364B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076989A1 (en) * | 2001-03-23 | 2002-10-03 | The University Of Newcastle Research Associates Limited | Protein phosphate inhibitors |
| CN103896954A (en) * | 2013-11-15 | 2014-07-02 | 绍兴文理学院 | Pyrazol norcantharidin derivative as well as preparation method and application thereof |
| CN106397445A (en) * | 2016-04-29 | 2017-02-15 | 绍兴文理学院 | Pyrazoles N-p-bromophenyl maleimide derivative containing chromone structure as well as preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 新型含色酮异噁唑类去甲斑蝥素衍生物的合成;黄文盈，等;《绍兴文理学院学报》;20150331;第35卷(第7期);10-13页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110105364A (en) | 2019-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108570086B (en) | Maleimide derivatives of the triazole structure containing arabinose and the preparation method and application thereof | |
| CN109053731B (en) | P-chloro-substituted pyridazinone-structure-containing spiro [ indolizine-pyrazoline ] derivative and preparation method and application thereof | |
| CN111233795A (en) | Preparation method and application of chiral gamma-butyrolactone compound and derivative thereof | |
| CN111269228B (en) | Preparation method of indolizine ring-1, 2-diketone and derivative thereof with fluorescence activity | |
| CN110105364B (en) | Pyrazole structure-containing N-p-chlorophenyl substituted maleimide alpha-terpinene cycloaddition derivative, and preparation method and application thereof | |
| CN110003224B (en) | Pyrazole structure-containing N-p-methylphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof | |
| CN109988176B (en) | Pyrazole structure-containing N-p-bromophenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof | |
| CN109988178B (en) | Pyrazole structure-containing N-p-nitrophenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof | |
| CN109988177B (en) | Pyrazole structure-containing N-p-methoxyphenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof | |
| CN109988179B (en) | Pyrazole structure-containing N-phenyl substituted maleimide alpha-terpinene cycloaddition derivative and preparation method and application thereof | |
| CN110128444B (en) | P-nitrophenyl substituted chromone structure-containing spiro [ indazole-isoxazole ] derivative, and preparation method and application thereof | |
| CN111303027A (en) | Fluroxacin acrylketone derivative and preparation method and application thereof | |
| CN107698571B (en) | Naphthalimide-coumarin DNA targeting double-intercalator, synthesis and application thereof | |
| CN109180583B (en) | Synthesis and application of naphthalimide derivative containing heterocyclic sulfone group and N-oxide | |
| CN108570085B (en) | Maleimide derivatives of the triazole structure containing xylose and the preparation method and application thereof | |
| CN108558968B (en) | Maleimide derivatives of the triazole structure containing glucose and the preparation method and application thereof | |
| CN110804039B (en) | Phthalimide-containing 1, 8-naphthalic anhydride derivatives, pharmaceutically acceptable salts thereof and application of anti-tumor drugs thereof | |
| CN110183467B (en) | P-methoxyphenyl substituted chromone structure-containing spiro [ indazole-isoxazole ] derivative, and preparation method and application thereof | |
| CN111606888B (en) | Pyrrole derivative and preparation method and application thereof | |
| CN116199687B (en) | Beta-carboline-3-position connected 1,2, 3-triazole compound as well as preparation method and application thereof | |
| CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
| CN110759920A (en) | P-methoxyphenyl substituted spiro [ indazole-pyrazoline ] derivative containing pyrazole structure and preparation method and application thereof | |
| CN106046019B (en) | A kind of Valine ring substituent norcantharidin derivative and the preparation method and application thereof | |
| CN108570087B (en) | Maleimide derivatives of the triazole structure containing galactolipin and the preparation method and application thereof | |
| CN114920684B (en) | Selenium-containing benzamide compound and synthetic method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220629 Address after: 250000 1422, building n, Hengda City, No. 58, Gongye North Road, Licheng District, Jinan City, Shandong Province Patentee after: Jinan Weiyang Technology Co.,Ltd. Address before: No. 2799, Qunxian Middle Road, Shaoxing City, Zhejiang Province Patentee before: SHAOXING UNIVERSITY YUANPEI College |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230111 Address after: 511400 Room 2202, 2203, 2204, 2205, Building 1, No. 6, Nanjiang Second Road, Zhujiang Street, Nansha District, Guangzhou, Guangdong Province Patentee after: Baisheng (Guangzhou) Biological Products Co.,Ltd. Address before: 250000 1422, building n, Hengda City, No. 58, Gongye North Road, Licheng District, Jinan City, Shandong Province Patentee before: Jinan Weiyang Technology Co.,Ltd. |
|
| TR01 | Transfer of patent right |